Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q3 2025 | 100.00% |
| Q2 2025 | 99.36% |
| Q1 2025 | -10613.70% |
| Q4 2024 | 0.00% |
| Q3 2024 | 100.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 100.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 100.00% |
| Q3 2022 | -1.19% |
| Q2 2022 | -0.52% |
| Q1 2022 | 1.78% |
| Q4 2021 | 95.44% |
| Q3 2021 | 26.15% |
| Q2 2021 | -10.48% |
| Q1 2021 | 34.81% |
| Q4 2020 | 41.23% |
| Q3 2020 | -9282.03% |
| Q2 2020 | 101.29% |
| Q1 2020 | -6.08% |
| Q4 2019 | -6.91% |
| Q3 2019 | -382.97% |
| Q2 2019 | 134.74% |
| Q1 2019 | -43.63% |
| Q4 2018 | -18.24% |
| Q3 2018 | -24.57% |
| Q2 2018 | -6.71% |
| Q1 2018 | -80.62% |
| Q4 2017 | -1.12% |
| Q3 2017 | 10.85% |
| Q2 2017 | -6.72% |
| Q1 2017 | -1.36% |
| Q4 2016 | -40.06% |
| Q3 2016 | -12.70% |
| Q2 2016 | -78.38% |
| Q1 2016 | -21.83% |
| Q4 2015 | 0.37% |